FDA Says Astellas' Bladder Drug Poses Heart, Liver Risks
An Astellas Pharma US Inc. bladder-control drug poses risks related to high blood pressure, increased heart rate and liver problems, the U.S. Food and Drug Administration revealed Tuesday ahead of an...To view the full article, register now.
Already a subscriber? Click here to view full article